Solvay S.A.

Solvay S.A.

SVYSF
Solvay S.A.US flagOther OTC
29.85
USD
-0.52
- -
3.12BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
114.71
127.71
120.4
97.24
106.28
109.41
108.81
94.18
110.45
76.9
57.84
48.86
45.43
43.76
Basic EPS, GAAP
3.05
0.96
4.85
6.01
10.27
8.49
1.14
-9.33
9.16
18.36
20.09
2.12
0.29
0.03
Free Cash Flow per Basic Share
4.88
7.62
3.01
7.81
7.43
8.59
9.29
6.85
8.34
10.57
8.13
3.14
4.42
3.84
Dividend per Share
3.88
3.5
3.86
3.74
3.83
3.98
4.13
4.06
4.16
4.02
4.07
2.48
2.5
2.43
Book Value per Share
79.94
74.34
90.81
94.04
93.31
101.88
92
69.77
84.32
102.18
12.04
12.82
9.76
10
Tangible Book Value per Share
26.65
21.17
-3.24
4.15
16.07
23.99
23.26
17.35
31.42
48.98
2.85
3.25
0.62
0.7
Basic Weighted Avg Shares
88
83
84
103
103
103
103
103
104
104
104
105
104
105
Sales/Revenue/Turnover
10,149
10,629
10,082
10,044
10,984
11,299
11,227
9,714
11,435
7,978
6,025
5,130
4,746
4,574
Operating Margin (%)
7.01
8.98
8.67
9.51
10.39
10.78
10.57
8.69
10.59
10.05
13.59
12.69
10.03
8.53
Depreciation Expense
872
1,430
783
1,025
1,152
921
1,032
2,416
849
923
994
362
404
387
Net Income, GAAP
270
80
406
621
1,061
877
118
-962
948
1,905
2,093
223
30
3
Effective Tax Rate (%)
44.97
24.49
14.62
- -
- -
9.48
206.76
- -
10.05
20.14
115.56
27.19
76.43
93.16
Profit Margin (%)
2.66
0.75
4.03
6.18
9.66
7.76
1.05
-9.9
8.29
23.88
34.74
4.35
0.63
0.07
Working Capital
3,162
1,336
2,282
1,596
1,929
2,672
2,181
1,709
1,302
2,125
522
563
311
267
LT Debt
2,809
1,485
5,628
4,087
2,900
2,971
3,227
3,117
2,520
2,407
243
1,728
1,800
1,819
Total Equity
7,452
6,778
9,668
9,957
9,754
10,626
9,624
7,303
8,851
10,664
1,306
1,404
1,082
1,111
Return on Invested Capital (%)
3.66
6.98
5.77
- -
- -
7.79
-8.88
- -
9.38
4.93
-1.66
18.5
3.33
0.78
Return on Capital (%)
3.56
3.81
4.02
- -
- -
7.37
-1.32
- -
8.79
14.93
26.98
12.14
1.61
0.2
Return on Common Equity (%)
4.09
1.17
5.08
6.49
10.97
8.7
1.18
-11.51
11.9
19.7
35.27
17.13
2.54
0.27

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
331
366
417
LT Borrowings
1,494
1,830
1,819
LT Finance Leases
306
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
104
104
104
Market Capitalization
2,831
2,619
2,774

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,156
2,190
2,047
Cash, Cash Equivalents & STI
555
501
376
Accounts Receivable, Net
622
678
664
Inventories
587
592
579
Total Current Liabilities
1,845
1,786
1,780
Payables & Accruals
- -
- -
- -
ST Debt
331
366
417
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-8.52%
-12.3%
-22.93%
Free Cash Flow
21.8%
1.07%
40%
Net Income, GAAP
-115.9%
-52.72%
-86.55%
Sales/Revenue/Turnover
-6.16%
-11.87%
-7.49%
Total Cash Common Dividend
-0.91%
-7.4%
0.38%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,298
1,333
1,245
1,254
5,130
2025
1,243
1,212
1,196
1,095
4,746
2026
1,142
1,141
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.02
0.64
0.18
0.29
2.12
2025
0.78
0.09
0.33
-0.91
0.29
2026
0.25
0.36
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.62
0.82
- -
- -
2.48
2025
0.97
1.46
- -
- -
2.5
2026
0.97
1.46
- -
- -
- -

Company Description

APIChatGPT
CEO
Philippe Kehren
Full Time Employees
8,443
Sector
Basic Materials
Industry
Chemicals
Address
Rue de Ransbeek, 310 Brussels BU Belgium 1120
IPO Date
Aug 3, 2012
Website
solvay.com
Business
Solvay SA engages in the production and sale of essential chemicals worldwide, focusing on basic and performance chemicals for resilient markets including consumer goods, healthcare, food, electronics, building and construction, automotive, and resources. The company offers soda ash and derivatives such as sodium bicarbonate and calcium chloride; hydrogen peroxide and peroxides; silica including highly dispersible silica; specialty chemicals; and products from Coatis such as guar derivatives and surfactants, marketed through over 1,000 product lines with safety data sheets in 39 languages. Founded in 1863 and headquartered in Neder-Over-Heembeek, Brussels, Belgium, Solvay operates approximately 45 industrial sites and 12 R&I centers across 41 countries in Europe, North America, Asia, Latin America, and other regions, employing over 9,000 people following its 2023 demerger that created Syensqo for specialty chemicals. Recent developments include signing two supply contracts in November 2025 with U.S. magnet manufacturers Permag and LCM for rare earths like NdPr and DyTb to bolster secure supply chains; a ten-year agreement with Sapio for Europe's first renewable hydrogen production hub by mid-2026; advancement of the For Generations sustainability roadmap targeting carbon neutrality by 2050 with 30% Scope 1 and 2 emissions reduction by 2030; ongoing operational transformation yielding €110 million in cost savings by end-2024 toward a €200 million target; expansion of recycling capacities at sites like Livorno, Italy for circular silica; completion of a share buyback program in October 2024; and strong 2024 financials with €4.7-4.88 billion in revenues and €1.246 billion underlying EBITDA despite market challenges.

Company News

APIChatGPT
  • Solvay SA (SLVYY) Q1 2026 Earnings Call Transcript

  • Short Interest in Solvay SA (OTCMKTS:SVYSF) Grows By 79.3%